Previous analyses of French Canadian population have also shown that these recurrent BRCA1 and BRCA2 mutations accounted for about 13% (diagnosis before age 41 years) and 3% (diagnosis before 80 years of age) of breast cancer cases and 8% of ovarian cancer cases [7-9]. Here, BRCA2 is linked to breast cancer.